LJUBLJANA (Slovenia), December 21 (SeeNews) – Slovenian drug maker Krka [LJE:KRKG] held 888,515 of its own shares as of Friday, representing 2.709% of the company's issued share capital, the company said.
Krka bought 11,383 shares for a total of 634,957 euro ($725,838) on the Ljubljana Stock Exchange between December 17 and December 20, the pharmaceuticals producer said in a bourse filing.
Prior to the transactions, Krka held a total of 877,132 of its own shares, representing 2.675% of all shares issued.
On July 28, 2017, Krka launched a share buyback programme, planning to acquire up to 2,720,248 shares over the following 36 months. The maximum pecuniary amount allocated to the programme is 227.8 million euro.
The company may dispose of the treasury shares acquired under the buyback programme in exchange for equity stakes in other companies by pursuing its merger and acquisition strategy, or by selling them to a strategic partner, Krka said at the time.
($ = 0.8747 euro)
KRKA d.d. is among the biggest companies in SEE. You can download our SEE Top 100 ranking
here or subscribe to our free Top 100 newsletter
here